When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider
GLP-3 is a hypothetical, undiscovered natural hormone
Each component carries its own literature BPC-157 in tissue-repair and gastrointestinal models, TB-500 (thymosin 4 fragment) in angiogenesis and cell-migration models, GHK-Cu in collagen and skin-remodeling work, and KPV as an anti-inflammatory tripeptide
PubMed Halawi H, Camilleri M, Acosta A, et al
Partner with Experts Who Care At Prescription Weight Loss, INC